Table 1.
Experimental systems for defining the inflammatory reflex
| Experimental model | Activation method | Result | Refs |
|---|---|---|---|
| Endotoxin-induced shock | Direct electical stimulation of cervical vagus nerve | Inhibition of serum TNF secretion and attenuation of shock | 2 |
| Sepsis induced by lethal peritonitis | Transcutaneous stimulation of cervical vagus nerve | Inhibition of serum HMGB1 secretion and improved survival | 97 |
| Pancreatitis | Administration of the α7nAChR agonist GTS-21 | Decreased pancreatitis severity | 33 |
| Vagotomy and administration of an α7nAChR antagonist | Increased pancreatitis severity | 33 | |
| Peripheral inflammation in subcutaneous tissue | Direct electical stimulation of cervical vagus nerve | Inhibition of neutrophil recruitment to the wound | 37 |
| Haemorrhagic shock | Direct electrical stimulation of cervical vagus nerve | Decreased hypotension severity, inhibition of TNF secretion, prolonged survival and downregulateion of NF-κB activity | 35 |
| Ischaemia-reperfusion injury secondary to suprarenal aortic clamping | Direct electrical stimulation of cervical vagus nerve | Inhibition of cytokine production in spleen, liver and heart, and attenuation of shock and tissue damage | 36 |
| Collagen-induced arthritis | Surgical stimulation of the cervical vagus nerve | Decreased arthritis severity | 95 |
| Administration of the α7nAChR agonist AR-R17779 | Inhibition of TNF secretion and decreased arthritis severity | 94 | |
| Vagotomy | Increased arthritis severity | 94 | |
| Ileus | Vagotomy | Increased ilieus severity | 41 |
| Administration of the α7nAChR agonist AR-R17779 | Attenuation of post-operative ileus and amelioration of intestinal inflammation | 41 | |
| Myocardial infarction | Direct electrical stimulation of cervical vagus nerve | Inhibition of cardiac myoglobin release during reperfusion injury | 98 |
| Colitis | Administration of α7nAChR antagonists and vagotomy | Increased colitis severity | 28,31,32 |
| Administration of α7nAChR agonists | Decreased colitis severity | 28,99,100 |
α7nAChR; nicotinic acetylcholine receptor subunit α7; HMBG1, high-mobility group box 1 protein; NF-κB, nuclear factor κB; TNF, tumour necrosis factor.